FGFR2 or FGFR3 alterations (mutation or fusion) are found in BC: although less than 10% of UC patients harbor an FGFR3 fusion, up to 60% have an FGFR mutation based on various reports. This evidence concerns the gene FGFR2 and breast cancer.